Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Les informations sur les projets et maintenant aussi les résumés de rapports Horizon 2020 sont disponibles sur CORDIS. Tous les projets H2020 peuvent être téléchargés depuis le Portail des données ouvertes de l'UE .

My refinements

Download results of this page

Affiner par:

Recherche avancée

Results 1 - 10 of 35
Order by: Results/page:
12 3 4 > 
TargetIng novel MEchanisms of Resolution in inflammation
ID: 281608
Date de début: 2012-01-01, Date de fin: 2015-12-31
Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The general objective of the TIMER Consortium is to identify and validate new molecules involved in the resolution of inflammation as a basis for...
Programme: FP7-HEALTH
Record Number: 100932
Last updated on: 2017-06-05
A BLUEPRINT of Haematopoietic Epigenomes
ID: 282510
Date de début: 2011-10-01, Date de fin: 2016-09-30
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mec...
Programme: FP7-HEALTH
Record Number: 99677
Last updated on: 2017-05-08
Development of an innovative paediatric formulation of an antiepileptic agent for the treatment of absence epilepsy in children
ID: 282559
Date de début: 2011-10-01, Date de fin: 2017-03-31
The KIEKIDS project is dedicated to the development of an innovative paediatric formulation of an antiepileptic agent for a safe alternative treatment of absence epilepsy in children. Development of such an age-appropriate formulation is regarded by The European Medicines Age...
Programme: FP7-HEALTH
Record Number: 100437
Last updated on: 2017-04-10
Evaluation and development of measures to uncover and overcome bias due to non-publication of clinical trials
ID: 282574
Date de début: 2011-09-01, Date de fin: 2014-06-30
The UNCOVER project is a direct contribution to overcome non-publication of clinical studies that have been designed and executed as randomized controlled trials (RCTs). RCTs provide the best utility as input to systematic medicinal reviews, one cornerstone of evidence-based ...
Programme: FP7-HEALTH
Record Number: 100179
Last updated on: 2017-03-27
Genetic studies of pre-eclampsia in Central Asian and European populations
ID: 282540
Date de début: 2011-11-01, Date de fin: 2016-10-31
Pre-eclampsia, one of the most dangerous cardiometabolic complications of pregnancy, claims the lives of 50,000 mothers and almost one million babies annually. Pre-eclampsia and other hypertensive disorders of pregnancy remain the second most common cause of maternal death. T...
Programme: FP7-HEALTH
Record Number: 101106
Last updated on: 2017-03-22
REsearch into POlicy to enhance Physical Activity
ID: 281532
Date de début: 2011-10-01, Date de fin: 2016-09-30
In line with the Call’s overall objective, the basic concept of the proposal is to integrate scientific research knowledge (=evidence), expert know-how and the real world policy making processes to increase synergy and sustainability in promoting health and preventing disease...
Programme: FP7-HEALTH
Record Number: 100087
Last updated on: 2017-03-22
Treatment of Adrenal Insufficiency in neonates- Development of a Hydrocortisone Preparation for the treatment of Adrenal Insufficiency in neonatesand infants
ID: 281654
Date de début: 2011-12-01, Date de fin: 2016-11-30
The aim of TAIN is to develop a neonatal formulation of hydrocortisone, a drug included in the EMA priority list that needs specific evaluation in the age range 0 – 2 years (neonates & infants). Hydrocortisone is an essential glucocorticoid hormone used as replacement therapy...
Programme: FP7-HEALTH
Record Number: 102053
Last updated on: 2016-12-26
Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities
ID: 282551
Date de début: 2011-10-01, Date de fin: 2014-09-30
EpoCan aims to develop and implement a comprehensive interdisciplinary strategy to assess the long-term risks of erythropoietin (EPO) and its derivatives (epoetins) on tumour growth progression and thromboembolic events in cancer patients, cardiovascular events, and the devel...
Programme: FP7-HEALTH
Record Number: 100286
Last updated on: 2016-12-12
NCDs and their social determinants in Mediterranean partner countries:  building sustainable research capacity for effective policy intervention
ID: 281640
Date de début: 2012-01-01, Date de fin: 2014-12-31
The main purpose of RESCAP-MED is to enhance the non-communicable diseases (NCDs) research landscape in southern and eastern Mediterranean countries by (a) strengthening capacity in a set of disciplines most relevant to improving public health and reducing health inequalities...
Programme: FP7-HEALTH
Record Number: 101814
Last updated on: 2016-10-31
Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe
ID: 282562
Date de début: 2011-09-01, Date de fin: 2015-08-31
Human papillomavirus (HPV) is responsible for approximately 25% of head and neck cancer (HNC) worldwide and appears to be associated with a better response to treatment and improved prognosis. Evidence suggests that HPV-induced HNC has steadily increased in the USA and some E...
Programme: FP7-HEALTH
Record Number: 100268
Last updated on: 2016-10-10
12 3 4 > 
List retrieved on: 2017-07-28